Cargando…
小细胞肺癌免疫治疗及预后相关标志物的研究进展
The efficacy of non-small cell lung cancer (NSCLC) has been obviously improved recent years, while the survival of small cell lung cancer (SCLC) patients remains inferior for limit treatment options. The incidence of SCLC accounts for 15% of the overall incidence of lung cancer, and it is characteri...
| Formato: | Online Artículo Texto |
|---|---|
| Lenguaje: | English |
| Publicado: |
中国肺癌杂志编辑部
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7118334/ https://www.ncbi.nlm.nih.gov/pubmed/32102135 http://dx.doi.org/10.3779/j.issn.1009-3419.2020.03.08 |